Biology Reference
In-Depth Information
Cherney, R., King, B., Gilmore, J., Liu, R., Covington, M., Duan, J. and Decicco, C.
(2006). Conversion of potent MMP inhibitors into selective TACE inhibitors,
Bioorg. Med. Chem. Lett
., 16, pp. 1028-1031.
Chilman-Blair, K., Leeson, P. and Bayes, M. (2003). Treatment of septic shock TLR4
(LPS) receptor antagonist,
Drugs of the Future
, 28, pp. 633-639.
Coley, W. B. (1896). The therapeutic value of the mixed toxins of the streptococcus of
Erysipelas and Bacillus prodigious in the treatment of inoperable malignant
tumors,
Am. J. Med. Sci
., 112, pp. 251-281.
Colotta, F., Ghezzi, P. and Mantovani, A. (1998). Interleukin 1. In
Cytokines
, ed. by
Mire-Sluis, A. and Thorpe, R., Academic Press: San Diego, CA, pp. 1-18.
Corti, A. and Ponzoni, M. (2004). Tumor vascular targeting with tumor necrosis factor α
and chemotherapeutic drugs,
Ann. NY Acad. Sci.
, 1028, pp. 104-112.
Curnis, F., Sachi, A. and Corti, A. (2002). Improving chemotherapeutic drug penetration
in tumors by vascular targeting and barrier alteration,
J. Clin. Invest
., 110, pp. 475-
482.
Darveau, R., Pham, T., Lemley, K., Reife, R., Bainbridge, B., Coats, S., Howald, W.,
Way, S. and Hajjar, A. (2004). Porphyromonas gingivalis lipopolysaccharide
contains multiple lipid A species that functionally interact with both Toll-like
receptors 2 and 4,
Infect. Immun
., 72, pp. 5041-5051.
Dauphinee, S. and Karsan, A. (2006). Lipopolysaccharide signaling in endothelial cells,
Laboratory Investigation
,
86, pp. 9-22.
Davey, P. and Ashrafian, H. (2000). New therapies for heart failure: is thalidomide the
answer?
QJM
, 93, pp. 305-311.
Demchenko, A. V., Wolfert, M. A., Santhanam, B., Moore, J. N. and Boons, G.-J. (2003).
Synthesis of biological evaluation of
Rhizobium sin-1
lipid A derivatives,
J. Am.
Chem. Soc.
, 125, pp. 6103-6112.
Dheen, S., Jun, Y., Yan, Z., Tay, S. and Ling, E. (2005). Retinoic acid inhibits expression
of TNF-α and iNOS in activated rat microglia,
Glia
, 50, pp. 21-31.
Dinarello, C., Cannon, J., Wolff, S., Bernheim, H., Beutler, B., Cerami, A., Figari, I.,
Palladino, M. and O'Connor, J. (1986). Tumor necrosis factor (cachectin) is an
endogenous pyrogen and induces production of interleukin 1,
J. Exp. Med.
, 163,
pp. 1433-1450.
Dinarello, C. (1989). Interleukin-1 and its biologically related cytokines. In
Advances in
Immunology
, vol. 44, ed. by Dixon, F., Academic Press: San Diego, CA, pp. 153-
205.
Ding, A., Porteu, F., Sanchez, E. and Nathan, C. (1990). Shared actions of endotoxin and
taxol TNF receptors and TNF release,
Science
, 248, pp. 370-372.
Dixon, D. R. and Darveau, R. P. (2005). Lipopolysaccharide heterogeneity: innate host
responses to bacterial modification of lipid A structure,
J. Dent. Res.
, 84, pp. 584-
595.
Dunzendorfer, S., Lee, H., Soldau, K. and Tobias, P. (2004). TLR4 is the signaling but
not the lipopolysaccharide uptake receptor,
J. Immunol.
, 173, pp. 1166-1170.
Durum, S., Schmidt, J. and Oppenheim, J. (1985). Interleukin 1: an immunological
perspective,
Annu. Rev. Immunol
., 3, pp. 263-287.
